american academy of cardiology glp 1 The conversation around GLP-1 medications is growing, and it goes beyond the number on the scale. According to the Heart Association, evidence suggests GLP-1s may support heart health and help reduce GLP-1s recommended for heart disease

& Hengartner, M

Addressing these neurological changes requires interventions capable of modulating neural function, not just blocking peripheral pain signals

AOD9604, by contrast, is not FDAapproved as an obesity medication, and while safety data are reassuring, its use for weight loss remains offlabel with mixed evidence for effectiveness

1.1 Glucose Metabolism is Reduced in Alzheimers and Parkinsons Disease A key element that has not received sufficient attention in understanding the pathophysiology of chronic neurodegenerative disorders such as AD and PD is the observation that glucose uptake and energy utilization in neurons is progressively reduced over time